Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company C3J Therapeutics Inc.
DescriptionSynthetic peptide targeting Streptococcus mutans derived from specifically targeted antimicrobial peptides (STAMPS) platform technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard Indication Dental (unspecified)
Indication DetailsPrevent dental caries
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today